El Salvador currently reports an pregnant women living with hiv antiretroviral therapy coverage for pmtct of 78%, which represents an increase of 2% (2.6%) from 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in El Salvador
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to El Salvador
PMTCT antiretroviral therapy coverage
More indicators for El Salvador
Male unintentional poisoning
0.4
0.0
(2019)
Female wasting in children
1.7%
+1%
(2014)
Female prevalence of HIV
0.1%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar259
+intl dollar42
(2021)
Birth registration
91.2%
-7.3%
(2018)
Contraceptive modern method prevalence
67.7%
+1.5%
(2014)
El Salvador PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 78% | +2% |
| 2021 | 76% | +17% |
| 2020 | 59% | -8% |
| 2019 | 67% | +9% |
| 2018 | 58% | -10% |
| 2017 | 68% | +3% |
| 2016 | 65% | -4% |
| 2015 | 69% | -1% |
| 2014 | 70% | -4% |
| 2013 | 74% | +9% |
| 2012 | 65% | +20% |
| 2011 | 45% | +6% |
| 2010 | 39% | -7% |
| 2009 | 46% | -8% |
| 2008 | 54% | +1% |
| 2007 | 53% | -13% |
| 2006 | 66% | -23% |
| 2005 | 89% | -7% |
| 2004 | 96% | +25% |
| 2003 | 71% | +23% |
| 2002 | 48% | +48% |
| 2001 | 0% | 0% |
| 2000 | 0% |